News & Insights

Gunderson Dettmer co-sponsored the Longwood Healthcare Leaders Boston CEO Summit 2025, a two-day, invitation-only conference that convenes approximately 250 biopharma CEOs, R&D executives, government officials, life science investors, and leading academics for off-the-record discussions

Gunderson Dettmer served as formation or investment counsel to 157 firms on TIME magazine’s first-ever America’s Top Venture Capital Firms of 2025 list, advising 90% of the Top 10 and more than 150 of the firms recognized

Global leader in AI-powered real-time information platforms, Dataminr, announces its $100 million convertible financing from funds managed by affiliates of Fortress Investment Group

Clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, Newleos Therapeutics, announces its $93.5 million Series A financing 

LMG Life Sciences recognizes Gunderson Dettmer with Impact Deal of the Year and names Boston associate Joel Diamond the US Rising Star—Financial and Corporate in its 2025 Life Sciences Americas Awards

Best Lawyers recognizes 38 Gunderson Dettmer attorneys across both the 2026 editions of The Best Lawyers in America list and Best Lawyers: Ones to Watch in America, continuing the legacy of celebrating exceptional legal professionals who have distinguished themselves through insight, expertise, and commitment to excellence

We are proud to announce that nine attorneys across five U.S. Gunderson Dettmer offices have been promoted.